ONCTERNAL THERAPEUTICS INC (ONCT)
Institutional ownership reported to the SEC as of Q2 2026, across 28 quarters.
1
Reporting holders
$75
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Union Bancaire Privee, UBP SA | $75 | 175 | 0.00% | 5q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $75 | 175 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $74 | 175 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 2 | $169 | 357 | 1 | 0 | 0 | 0.0% |
| Q3 2025 | 1 | $73 | 175 | 0 | 0 | 0 | 0.0% |
| Q2 2025 | 1 | $74 | 175 | 1 | 0 | 0 | 0.0% |
| Q4 2024 | 2 | $10 | 18 | 0 | 0 | 0 | 0.0% |
| Q3 2024 | 21 | $454.4K | 344,251 | 2 | 5 | 4 | 0.0% |
| Q2 2024 | 25 | $3.7M | 482,271 | 4 | 4 | 5 | 0.0% |
| Q1 2024 | 22 | $4.1M | 453,746 | 20 | 0 | 2 | 0.0% |
| Q4 2023 | 39 | $4.4M | 8,159,527 | 8 | 5 | 6 | 0.0% |
| Q3 2023 | 48 | $2.7M | 8,890,511 | 4 | 9 | 6 | 0.0% |
| Q2 2023 | 50 | $3.1M | 9,013,200 | 4 | 7 | 8 | 0.1% |
| Q1 2023 | 47 | $6.3M | 8,022,951 | 4 | 7 | 8 | 0.1% |
| Q4 2022 | 53 | $7.2M | 7,251,978 | 12 | 6 | 10 | 0.4% |
| Q3 2022 | 58 | $8.9M | 9,858,316 | 3 | 10 | 19 | 0.7% |
| Q2 2022 | 69 | $12.8M | 11,390,366 | 19 | 16 | 20 | 1.6% |
| Q1 2022 | 77 | $18.9M | 13,388,195 | 13 | 21 | 25 | 1.3% |
| Q4 2021 | 82 | $31.1M | 13,536,276 | 15 | 21 | 23 | 1.2% |
| Q3 2021 | 78 | $59.5M | 13,612,220 | 9 | 27 | 22 | 4.6% |
| Q2 2021 | 85 | $68.6M | 13,720,063 | 26 | 24 | 18 | 5.0% |
| Q1 2021 | 65 | $86.8M | 9,903,625 | 28 | 18 | 11 | 4.9% |
| Q4 2020 | 54 | $42.2M | 8,443,538 | 37 | 8 | 2 | 2.0% |
| Q3 2020 | 21 | $7.2M | 4,210,029 | 4 | 4 | 4 | 0.0% |
| Q2 2020 | 19 | $7.7M | 2,703,398 | 1 | 6 | 3 | 0.0% |
| Q1 2020 | 20 | $4.0M | 1,373,854 | 2 | 4 | 6 | 0.0% |
| Q4 2019 | 22 | $5.0M | 1,277,878 | 2 | 4 | 9 | 0.0% |
| Q3 2019 | 21 | $5.6M | 1,127,262 | 8 | 5 | 5 | 0.1% |
| Q2 2019 | 24 | $2.1M | 289,712 | 24 | 0 | 0 | 6.3% |